Robin Carhart-Harris

Ayelet Waldman, author of "A Really Good Day," shares her transformative experience with microdosing and its positive effects on her life. Robin Carhart-Harris, head of psychedelic research at Imperial College London, discusses the neurological mechanisms behind psychedelics and their therapeutic potential. Christian Angermayer, an investor in psychedelic innovations, highlights the shift in mental health treatment perspectives. The conversation explores microdosing’s role in combating depression, the opioid crisis, and the evolving legal landscape surrounding psychedelics.

Robin Carhart-Harris, Director of the Centre for Psychedelic Research at Imperial College London, leads cutting-edge studies on psychedelics and their therapeutic benefits. He discusses the historical challenges faced in psychedelic research and the evolving understanding of their effects on mental health, including conditions like depression and addiction. Carhart-Harris reveals how psychedelics alter brain function, promote cognitive flexibility, and can lead to profound self-discoveries. He also addresses societal perceptions of psychedelics versus alcohol, advocating for a mindful approach to their use.